Delivery Order SPE2DB22D1202-SPE2DB25FVFS1
Award Date 7/25/25
Potential Completion Date 7/28/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,235.22 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 mL) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract...
- This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order is for 400 mg/200 mL of the drug Ropivacaine 0.2%, totaling $3,736.40. The contract does not have a set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4556997205 - Ropivacaine 0.2% 200 mg/100 ml 100 ml pharmaceuticals. The contract award, valued at $2,695.54, has an ultimate completion date of April 27, 2022. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 with a...
- This contract award is for the delivery of 400 mg/200 mL vials of ropivacaine 0.2% solution, a local anesthetic medication, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $3,873.51, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 27, 2023 and is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,478.12 order is for the pharmaceutical product Ropivacaine 0.2% 400 mg/200 ml, with a completion date of February 21, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor and a for-profit organization. This delivery order is part of a larger indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,775.55, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml (200 ml) medical supplies. The contract has an ultimate completion date of May 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
- The Defense Logistics Agency Troop Support Medical awarded a $3,440.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 400 milligrams of ropivacaine hydrochloride 0.2% solution in 200 milliliter vials. Performance will take place in Conshohocken, Pennsylvania under contract number 4561841756 for the delivery of the specified pharmaceutical product on August 17-18, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will be responsible for fulfilling the...
- This is a $2,665.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566997560 - Ropivacaine 0.2% 400 mg/200 mL 200 mL, with a performance period running through January 22, 2025. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,731.07, is for the supply of 400 mg/200 mL ropivacaine 0.2% injectable medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- The Defense Logistics Agency awarded a delivery order under an unspecified government-wide acquisition contract to Amerisourcebergen Drug Corporation for $3,679.43. The firm fixed price order is for 400 milligrams of the anesthetic Ropivacaine in 200 milliliter containers. Place of performance will be Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order has a period of performance from August 2, 2023 through August 3, 2023 to supply the anesthetic in support of the Defense...